Back to Balyasny Asset Management L.P. Balyasny Asset Management L.P.

VKTX

22 quarters

Position history for Balyasny Asset Management L.P.Balyasny Asset Management L.P.'s holdings in Viking Therapeutics, Inc.

Yes. Balyasny Asset Management holds 115,906 shares of VKTX (Viking Therapeutics), worth $4.5M, as of its Q2 2026 13F filing. It increased the position from 36,493 shares in Q1 2026. Balyasny Asset Management has held VKTX since Q1 2026, across 2 quarterly 13F filings.

Current Value

$4.5M

Current Shares

115,906

Total Value Change

+$1.7M

Total Shares Change

-247,700

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
115,906
+217.6%
$4.5M0.0%$39.01
43
2026-Q1
New
36,493
-
$1.2M0.0%$32.54
35
2025-Q2
Exited
0
-100.0%
$00.0%$26.50
0
2025-Q1
Increased
1.6M
+91.6%
$39.8M0.1%$24.15
46
2024-Q4
New
860,449
-
$34.6M0.1%$40.24
40
2024-Q3
Exited
0
-100.0%
$00.0%$63.31
0
2024-Q2
Increased
185,382
+70.7%
$9.8M0.0%$53.01
41
2024-Q1
Decreased
108,595
-95.2%
$8.9M0.0%$82.00
0
2023-Q4
Increased
2.2M
+5.7%
$41.8M0.1%$18.61
31
2023-Q3
Increased
2.1M
+244.9%
$23.5M0.0%$11.07
46
2023-Q2
Increased
615,268
+10.5%
$10M0.0%$16.21
31
2023-Q1
Increased
556,607
+436.4%
$9.3M0.0%$16.65
45
2022-Q4
Decreased
103,770
-96.1%
$975,4380.0%$9.40
0
2022-Q3
Increased
2.7M
+1.2%
$7.3M0.0%$2.72
28
2022-Q2
New
2.6M
-
$7.6M0.0%$2.89
38
2020-Q3
Exited
0
-100.0%
$00.0%$5.82
0
2020-Q2
New
10,410
-
$75,0000.0%$7.21
29
2019-Q4
Exited
0
-100.0%
$00.0%$8.02
0
2019-Q3
Decreased
10,245
-44.6%
$70,0000.0%$6.88
0
2019-Q2
Decreased
18,478
-70.0%
$153,0000.0%$8.30
0
2019-Q1
Decreased
61,658
-83.0%
$613,0000.0%$9.94
0
2018-Q4
First report
363,606
-
$2.8M0.0%$7.65
0

Other major holders of VKTX: FMR LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used